[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339885-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339885-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ocoxin-oral-solution-triggers-dna-damage-and-cell-death-in-ovarian-cancer","Ocoxin Oral Solution Triggers DNA Damage and Cell Death in Ovarian Cancer","","Ovarian cancer remains the most lethal reproductive malignancy, largely because late diagnosis restricts surgery and effective medical therapy. New interventions are needed to improve patient survival and quality of life. This study evaluates the nutritional supplement Ocoxin Oral Solution (OOS) in ovarian cancer models. OOS inhibits proliferation across ovarian cancer cell lines, rapidly inducing cell death via activation of the DNA damage checkpoint, including CHK1/CHK2 phosphorylation and H2AX phosphorylation, and suppresses tumor growth in vivo while enhancing standard treatments.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ocoxin-oral-solution-triggers-dna-damage-and-cell-death-in-ovarian-cancer/339885/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ocoxin-oral-solution-triggers-dna-damage-and-cell-death-in-ovarian-cancer/339885.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in ovarian cancer therapy?","Question",{"text":63,"@type":64},"Ovarian cancer has poor outcomes due to late diagnosis, which limits curative surgery and effective treatments, motivating the need for new therapeutic strategies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does Ocoxin Oral Solution (OOS) affect ovarian cancer cells in vitro?",{"text":68,"@type":64},"OOS inhibits proliferation of multiple ovarian cancer cell lines and induces fast cell death in a time- and dose-dependent manner, especially in endometrioid subtype models.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism links OOS treatment to cancer cell death?",{"text":72,"@type":64},"The study identifies DNA damage checkpoint activation after OOS exposure, shown by phosphorylation of CHK1 and CHK2, followed by phosphorylation of histone H2AX.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339885,1790183741,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","nutrients   \nArticle  \nOcoxin Oral Solution Triggers DNA Damage and Cell Death in Ovarian Cancer  \nSheila Almaraz-Postigo 1, Eduardo Sanz 2, Atanasio Pandiella 1 and Elena Díaz-Rodríguez 1,3, *  \nCitation: Almaraz-Postigo, S.; Sanz, E.; Pandiella, A.; Díaz-Rodríguez, E. Ocoxin Oral Solution Triggers DNA Damage and Cell Death in Ovarian Cancer. Nutrients 2024, 16, 2416 . [https://doi.org/10.3390/nu16152416](https://doi.org/10.3390/nu16152416)  \nAcademic Editor: Mariusz Chabowski  \nReceived: 18 June 2024  \nRevised: 19 July 2024  \nAccepted: 24 July 2024  \nPublished: 25 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC), Instituto de Investigación Biomédica de Salamanca (IBSAL) and Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Campus Miguel de Unamuno, 37007 Salamanca, Spain; [salmaraz@usal.es](salmaraz@usal.es) (S.A.-P.); [atanasio@usal.es](atanasio@usal.es) (A.P.)  \n2 Catalysis S.L., 28016 Madrid, Spain; [eduardo@catalysis.es](eduardo@catalysis.es)  \n3 Department of Biochemistry, Universidad de Salamanca, 37008 Salamanca, Spain  \n* Correspondence: ediaz@usal.es  \nAbstract: Ovarian cancer is the most fatal of all the reproductive cancers within the female population, mainly due to its late diagnosis that limits surgery and medical treatment. Classically, ovarian cancer therapy has included conventional chemotherapy, and other therapeutic approaches are now being used to treat these patients, but the outcomes of the disease are still poor. Therefore, new strategies are needed to improve life expectancy and life quality of ovarian cancer patients. Considering that, we investigated the effect of the nutritional supplement Ocoxin Oral Solution (OOS) in ovarian cancer models. OOS contains several nutritional supplements, some of them with demonstrated antitumoral action. In vitro studies showed that OOS inhibited the proliferation of several ovarian cancer cell lines, especially of those representative of the endometrioid subtype, in a time-and dose-dependent manner. A fast cell death induction after OOS treatment was observed, and when the molecular mechanisms leading to this effect were investigated, an activation of the DNA damage checkpoint was detected, as shown by activation (phosphorylation) of CHK1 and CHK2 kinases that was followed by the phosphorylation of the target protein histone H2AX. When tested in animal models of ovarian cancer, OOS reduced tumor growth without any observed secondary effects. Moreover, such reduction in tumor proliferation was caused by the induction of DNA damage as corroborated by the in vivo phosphorylation of CHK2 and Histone H2AX. Finally, OOS potentiated the action of carboplatin orolaparib, the standard of care treatments used in ovarian clinics, opening the possibility of including OOS in combination with those standard of care agents in patients with ovarian cancer.  \nKeywords: ovarian cancer; OOS; antioxidants; DNA damage; cell death  \n1. Introduction  \nWorldwide, ovarian cancer is diagnosed every year in 295,000 women, and 185,000 of them will die from this malignancy [1,2], being that it is the most fatal of all reproductive cancers and the fifth most common cause of cancer-associated death in woman. This poor outcome is due to the lack of effective screening procedures combined with nonspecific symptoms of the disease that, altogether, cause the diagnosis of the disease to occur at advanced stages, limiting possibilities for surgery and medical treatment [2,3] .  \nClassically, ovarian cancer therapy has included surgical resection and chemotherapy reg","cbCaigiUklF039Tk","https://ap.wps.com/l/cbCaigiUklF039Tk","pdf",3464637,15,"English","# Abstract\n# Introduction","[{\"question\":\"What problem does the study address in ovarian cancer therapy?\",\"answer\":\"Ovarian cancer has poor outcomes due to late diagnosis, which limits curative surgery and effective treatments, motivating the need for new therapeutic strategies.\"},{\"question\":\"How does Ocoxin Oral Solution (OOS) affect ovarian cancer cells in vitro?\",\"answer\":\"OOS inhibits proliferation of multiple ovarian cancer cell lines and induces fast cell death in a time- and dose-dependent manner, especially in endometrioid subtype models.\"},{\"question\":\"What mechanism links OOS treatment to cancer cell death?\",\"answer\":\"The study identifies DNA damage checkpoint activation after OOS exposure, shown by phosphorylation of CHK1 and CHK2, followed by phosphorylation of histone H2AX.\"}]","Ocoxin Oral Solution Triggers DNA Damage and Cell Death in Ovarian Cancer | PDF",1790032933,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/010cf597ae69bf819f18b0a7e36c249b.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5465b6023824c809200d966da709f923.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f19071bbf0128568e2107ba707dd3dad.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0631a4e6cb226823170aafa09982a94.webp",980,1385]